Search research articles
Contact Us
Filters
Showing results (431-440 of 716) with videos related to
Page
of 72
Sort By:
American Heart Journal
|
November 13, 2019
Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease
Jay S Shavadia, Yinggan Zheng, Jennifer B Green, et al.
The American Journal of Cardiology
|
March 27, 2012
Relation of prolonged tissue Doppler imaging-derived atrial conduction time to atrial arrhythmia in adult patients with congenital heart disease
Annelies E van der Hulst, Arno A W Roest, Eduard R Holman, et al.
Diabetes Research (Edinburgh, Scotland)
|
December 1, 1988
Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes
A Clark, C A Wells, I D Buley, et al.
The New England Journal of Medicine
|
September 19, 2006
Effect of ramipril on the incidence of diabetes
, Jackie Bosch, Salim Yusuf, et al.
Cardiovascular Therapeutics
|
February 27, 2010
Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials
Henry Krum, John J V McMurray, Edward Horton, et al.
Diabetes Research and Clinical Practice
|
November 23, 2021
Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial
Frauke Becker, Helen A Dakin, Shelby D Reed, et al.
Cardiovascular Diabetology
|
September 13, 2022
Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study
Shishi Xu, Ruth L Coleman, Qin Wan, et al.
Arthritis and Rheumatism
|
April 1, 2009
No increased risk of valvular heart disease in adult poststreptococcal reactive arthritis
J M van Bemmel, V Delgado, E R Holman, et al.
Diabetes, Obesity & Metabolism
|
September 14, 2016
Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome
Dirk J Blom, Michael J Koren, Eli Roth, et al.
Circulation. Arrhythmia and Electrophysiology
|
November 26, 2014
Re-entry using anatomically determined isthmuses: a curable ventricular tachycardia in repaired congenital heart disease
Gijsbert F L Kapel, Tobias Reichlin, Adrianus P Wijnmaalen, et al.
Page
of 72
Search research articles
Search
Showing results (431-440 of 716) with videos related to
Sort By:
Page
of 72
American Heart Journal
|
November 13, 2019
Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease
Jay S Shavadia, Yinggan Zheng, Jennifer B Green, et al.
The American Journal of Cardiology
|
March 27, 2012
Relation of prolonged tissue Doppler imaging-derived atrial conduction time to atrial arrhythmia in adult patients with congenital heart disease
Annelies E van der Hulst, Arno A W Roest, Eduard R Holman, et al.
Diabetes Research (Edinburgh, Scotland)
|
December 1, 1988
Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes
A Clark, C A Wells, I D Buley, et al.
The New England Journal of Medicine
|
September 19, 2006
Effect of ramipril on the incidence of diabetes
, Jackie Bosch, Salim Yusuf, et al.
Cardiovascular Therapeutics
|
February 27, 2010
Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials
Henry Krum, John J V McMurray, Edward Horton, et al.
Diabetes Research and Clinical Practice
|
November 23, 2021
Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial
Frauke Becker, Helen A Dakin, Shelby D Reed, et al.
Cardiovascular Diabetology
|
September 13, 2022
Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study
Shishi Xu, Ruth L Coleman, Qin Wan, et al.
Arthritis and Rheumatism
|
April 1, 2009
No increased risk of valvular heart disease in adult poststreptococcal reactive arthritis
J M van Bemmel, V Delgado, E R Holman, et al.
Diabetes, Obesity & Metabolism
|
September 14, 2016
Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome
Dirk J Blom, Michael J Koren, Eli Roth, et al.
Circulation. Arrhythmia and Electrophysiology
|
November 26, 2014
Re-entry using anatomically determined isthmuses: a curable ventricular tachycardia in repaired congenital heart disease
Gijsbert F L Kapel, Tobias Reichlin, Adrianus P Wijnmaalen, et al.
Page
of 72